John F Crowley Intellia Therapeutics, Inc. (NTLA) insider trading activity

John F Crowley is Director of Intellia Therapeutics, Inc.. Currently has a direct ownership of 11,716 shares of NTLA, which is worth approximately $167,538. The most recent transaction as insider was on Jun 14, 2023, when has been sold 4,425 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 11.7K

0% 3M change

0% 12M change

Total Value Held $167,538

John F Crowley Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 14 2023	BUY Grant, award, or other acquisition	-	4,425 Added 27.41%	11,716 Common Stock
Jun 14 2022	BUY Grant, award, or other acquisition	-	5,197 Added 41.62%	7,291 Common Stock
Oct 11 2021	SELL Open market or private sale	$298,875 $119.55 p/Share	2,500 Reduced 54.42%	2,094 Common Stock
Oct 11 2021	BUY Exercise of conversion of derivative security	$47,075 $18.83 p/Share	2,500 Added 35.24%	4,594 Common Stock
Oct 05 2021	SELL Open market or private sale	$1,308,400 $130.84 p/Share	10,000 Reduced 82.69%	2,094 Common Stock
Oct 05 2021	BUY Exercise of conversion of derivative security	$188,300 $18.83 p/Share	10,000 Added 45.26%	12,094 Common Stock
Jun 23 2021	BUY Grant, award, or other acquisition	-	2,094 Added 50.0%	2,094 Common Stock

Also insider at

FOLD

AMICUS THERAPEUTICS, INC. Healthcare

Executive Chairman

TRDA

Entrada Therapeutics, Inc. Healthcare

Director

JFC

John F Crowley

Director

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NTLA shares.

Notify only if

Value

Insider Trading

Get notified when an Intellia Therapeutics, Inc. insider buys or sells NTLA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Intellia Therapeutics, Inc.

Track Activities on NTLA

Account